Please login to the form below

Not currently logged in
Email:
Password:

GSK's Lawson elected PAGB president

He will help lead OTC trade body after departure of Novartis' David Barnett
pagb Carlton Lawson

The Proprietary Association of Great Britain (PAGB), which represents OTC companies in the UK, has elected Carlton Lawson of GlaxoSmithKline (GSK) as its new president.

On March 3 Lawson, who is general manager of GSK's consumer health business in the UK and Ireland, will take over from Novartis' David Barnett who moves to a new position in Latin America.

Lawson was only appointed to his current GSK position last year having previously served as global business lead in oral heath at the healthcare giant.

This followed a career that included senior sales and brand roles at Warner Lamber, Pfizer and Johnson & Johnson. He has experience with the PAGB too, being elected vice president in 2007.

Matthew Speers, chief executive of the PAGB, said he was “looking forward to working with Lawson”.

“Having served on the PAGB board previously when he was general manager at Johnson & Johnson, he has in-depth knowledge of PAGB and this past experience will be a great asset in helping drive forward PAGB's work programme, particularly the better regulation agenda,” said Speers.

26th February 2014

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
11 London

11 London is a strategic and creative agency working in the fields of health and humanity – complex areas, but...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics